We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

79 hedge funds and large institutions have $34.3M invested in Microbot Medical in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

100% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 13

51% more capital invested

Capital invested by funds: $22.8M → $34.3M (+$11.5M)

13% more funds holding

Funds holding: 70 → 79 (+9)

4.24% more ownership

Funds ownership: 16.96% → 21.2% (+4.2%)

17% less call options, than puts

Call options by funds: $850K | Put options by funds: $1.03M

Holders
79
Holders Change
+9
Holders Change %
+12.86%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
26
Reduced
13
Closed
11
Calls
$850K
Puts
$1.03M
Net Calls
-$177K
Net Calls Change
-$1.13M

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$1.07M
2
AA
Ancora Advisors
Ohio
+$1.07M
3
Millennium Management
Millennium Management
New York
+$911K
4
UBS Group
UBS Group
Switzerland
+$830K
5
Stifel Financial
Stifel Financial
Missouri
+$686K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$717K
2
6CM
683 Capital Management
New York
-$192K
3
OAC
OMERS Administration Corp
Ontario, Canada
-$135K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$132K
5
Jane Street
Jane Street
New York
-$125K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAS
51
CTC Alternative Strategies
Illinois
$28.2K +$26.2K +11,718 New
Cerity Partners
52
Cerity Partners
New York
$25.6K +$23.8K +10,633 New
CA
53
Cornerstone Advisory
Maryland
$24.1K – – –
OCA
54
OpenArc Corporate Advisory
Georgia
$24.1K +$22.3K +10,000 New
Wells Fargo
55
Wells Fargo
California
$21K -$2 -1 -0%
TRCT
56
Tower Research Capital (TRC)
New York
$20.6K +$16.7K +7,486 +706%
BL
57
BFSG LLC
California
$13.3K – – –
Osaic Holdings
58
Osaic Holdings
Arizona
$9.65K +$2.23K +1,000 +33%
Carson Wealth (CWM LLC)
59
Carson Wealth (CWM LLC)
Nebraska
$6.63K +$4 +2 +0.1%
SS
60
SBI Securities
Japan
$6.58K +$223 +100 +4%
SPIA
61
Steward Partners Investment Advisory
New York
$5.54K +$2.23K +1,000 +77%
Royal Bank of Canada
62
Royal Bank of Canada
Ontario, Canada
$5K – – –
AW
63
Avion Wealth
Texas
$3K – – –
AAP
64
Arax Advisory Partners
Colorado
$2.67K +$936 +419 +61%
MCM
65
MAI Capital Management
Ohio
$2.41K +$2.23K +1,000 New
LSA
66
Leonteq Securities AG
Switzerland
$1.59K – – –
Jones Financial Companies
67
Jones Financial Companies
Missouri
$1.2K +$1.12K +500 +50,000%
EWA
68
EverSource Wealth Advisors
Alabama
$860 – – –
CA
69
Clearstead Advisors
Ohio
$663 – – –
AF
70
Allworth Financial
California
$314 – – –
S
71
SignatureFD
Georgia
$43 – – –
Fidelity Investments
72
Fidelity Investments
Massachusetts
$10 +$7 +3 +300%
AUB
73
Atlantic Union Bankshares
Virginia
$3 – – –
FS
74
Financially Speaking
Colorado
$3 – – –
WWM
75
Wolff Wiese Magana
California
$3 – – –
1 2
3
4

MBOT Hedge Fund Activity: Q1 2026 in Review

79 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2026, worth a combined $34.3M — up 51% from $22.8M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new MBOT positions and 11 closed out — a net gain of 11 holders — while 26 added to existing stakes and 13 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $1.07M. The largest seller was Susquehanna International Group, cutting an estimated $717K.

  • 79 institutional investors held Microbot Medical (MBOT) as of Q1 2026, up from 70 in Q4 2025.
  • Funds reported $34.3M of Microbot Medical stock for Q1 2026, up 51% quarter-over-quarter.
  • 22 funds opened new Microbot Medical positions in Q1 2026 and 11 closed out, a net change of +11 holders.
  • The largest Microbot Medical buyer in Q1 2026 was Marshall Wace, an estimated $1.07M added.
  • The largest Microbot Medical seller in Q1 2026 was Susquehanna International Group, an estimated $717K sold.

Based on aggregated 13F filings for Q1 2026.